IRCT2017012121315N7
Completed
未知
A Non-randomized, Single-armed Clinical trial study to determine the therapeutic efficacy of Pegfilgrastim (CinnaGen Company) to treatment of anemia consequent taxans chemotherapy in breast cancer patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Condition 1: Breast Cancer. Condition 2: Neutropenia.
- Sponsor
- CinnaGen Company
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •breast cancer stage I\-III and women between the age of 18\-65 years at the time of signing the informed consent form.
- •Exclusion criteria: patients with metastatic breast cancer; liver failure or myelosuppression; pregnancy or lactation and dissatisfaction.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Clinical trial on effectiveness of Varmam therapy for Otrai thalai vali ( Migraine )Health Condition 1: G439- Migraine, unspecifiedCTRI/2023/09/057265ational Institute of Siddha
Completed
Phase 4
Comparison of safety and efficaccy of levocetrizine and olopatadine in patients suffering from hives for more than 6 weeksHealth Condition 1: null- Chronic UrticariaCTRI/2011/08/001965Burdwan Medical College and Hospital120
Recruiting
Phase 1
Clinical trial study of xingnao-jianshen prescriptions for ischemic stroke (experimental phlegm-heat and fu-organism)Ischemic strokeITMCTR2100004777Affiliated Hospital of Changchun University of Traditional Medicine
Completed
Not Applicable
Effect of platelet rich plasma and silver ion dressing on venous ulcer healingHealth Condition 1: O- Medical and SurgicalCTRI/2023/04/051654Institute of medical sciences40
Not yet recruiting
Phase 2
Clinical Trial On UTICTRI/2021/11/037743Ministry Of AYUSH